Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00040833 · ClinicalTrials.gov registry record · Phase 2
Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00040833: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00040833 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00040833, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Acupuncture and acupressure may help relieve moderate or severe pain associated with stage III or stage IV pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of acupuncture and accupressure in treating patients who have moderate or severe pain associated with stage III or stage IV pancreatic cancer.
Interventions
- PROCEDURE pain therapy
- PROCEDURE complementary or alternative medicine procedure
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-02 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
What the finished NCT00040833 record still lists
NCT00040833 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.
NCT00040833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00040833 about?
NCT00040833 is a clinical study titled "Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer". RATIONALE: Acupuncture and acupressure may help relieve moderate or severe pain associated with stage III or stage IV pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of acupuncture and accupressure in treating patients who have moderate or severe pain associated with stage III...
What is the current status of trial NCT00040833?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-02. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00040833?
The interventions under investigation include: pain therapy (PROCEDURE), complementary or alternative medicine procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00040833?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia